|
GINS4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.58470000003008E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.406390E-04 |
| Normal-vs-Stage2 |
4.874300E-02 |
| Normal-vs-Stage3 |
5.216000E-03 |
| Normal-vs-Stage4 |
6.15739999999532E-05 |
| Stage1-vs-Stage2 |
5.038400E-01 |
| Stage1-vs-Stage3 |
6.721800E-01 |
| Stage1-vs-Stage4 |
2.032100E-02 |
| Stage2-vs-Stage3 |
4.273000E-01 |
| Stage2-vs-Stage4 |
4.041000E-01 |
| Stage3-vs-Stage4 |
1.707980E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.67339999998817E-06 |
| Normal-vs-AfricanAmerican |
1.860380E-03 |
| Normal-vs-Asian |
1.468440E-01 |
| Caucasian-vs-AfricanAmerican |
8.085400E-01 |
| Caucasian-vs-Asian |
8.549400E-01 |
| AfricanAmerican-vs-Asian |
7.484200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1226999999957E-05 |
| Normal-vs-Female |
7.53380000000359E-05 |
| Male-vs-Female |
7.352600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.051700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.75601999999886E-05 |
| Normal-vs-Age(61-80Yrs) |
2.416700E-04 |
| Normal-vs-Age(81-100Yrs) |
3.335800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.342800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.979160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.506200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.510000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.888000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.292210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.582200E-03 |
| Normal-vs-Grade 2 |
7.993500E-04 |
| Normal-vs-Grade 3 |
1.155800E-04 |
| Normal-vs-Grade 4 |
1.178950E-03 |
| Grade 1-vs-Grade 2 |
3.872200E-01 |
| Grade 1-vs-Grade 3 |
5.722200E-01 |
| Grade 1-vs-Grade 4 |
3.236200E-01 |
| Grade 2-vs-Grade 3 |
4.406000E-01 |
| Grade 2-vs-Grade 4 |
3.730100E-02 |
| Grade 3-vs-Grade 4 |
6.834100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.777830E-02 |
| Normal-vs-ccB subtype |
1.6200099999919E-05 |
| ccA subtype-vs-ccB subtype |
1.575020E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.96271999999276E-05 |
| Normal-vs-N1 |
6.739000E-03 |
| N0-vs-N1 |
1.563700E-02 |
|
|
